F 0645
PASARR screening for Mental disorders or Intellectual Disabilities
Level of Harm - Minimal harm
or potential for actual harm
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY**
Residents Affected - Few
Based on interviews and record reviews, the facility failed to ensure the completion of pre-admission
screening for individuals with a mental disorder and individuals with an intellectual disability for one
(Resident #39) of 27 residents in the sample.
The findings include:
A medical record review for Resident #39 indicated he was admitted to the facility on [DATE]. His diagnoses
included intermittent, explosive disorder, bipolar disorder and schizophrenia. His physician's orders
revealed orders for Paroxetine 30 milligrams (Mg) by mouth (PO) every day (QD) for depression, and
Risperidone 1 mg two times a day (BID) for bipolar disorder. A 5-day admission Minimum Data Set (MDS)
assessment revealed the resident had not been evaluated via Level II Pre-admission Screening and
Resident Review (PASRR) to determine serious mental illness and/or mental retardation or related
condition. Further review indicated that Resident #39 had a Brief Interview for Mental Status score (BIMS)
of 07 out of 15 possible points, indicating severe cognitive impairment. The resident also reported feeling
depressed or hopeless, feeling tired and having little energy for 2- 6 days, and received antispychotic and
antidepressant medication for 7 days and antianxiety medication for 3 days during the look back period. His
care plan indicated that he was on antianxiety, antidepressant and psychotropic medications related to
anxiety, depression and bipolar disorders respectively.
A review of the Level I PASRR dated 4/19/2021, Section 1, revealed the following: Schizophrenia onset
prior to [AGE] years of age. Currently receiving services for mental illness (MI), and Intellectual disability
(ID). Section II 1. indicated that Resident #39 had or may have had a disorder in functional limitation in
major life activities that would otherwise be appropriate for the individual's developmental stage. Previously
received services for MI and ID. Section IV was incomplete. (Copy obtained)
A review of the Hospital Discharge summary dated [DATE], revealed: Past medical history indicated mental
deficiency, schizophrenia, and intermittent explosive disorder. Resident's father described him as never
having issues with depression, always just wild due to his schizophrenia and requiring seroquel, risperdal,
and carbamazepine, and never on an anti-depressant.
During an interview on 06/09/2021 at 12:35 PM, the Director of Nursing (DON) and the Assistant Director
of Nursing (ADON) were asked about Resident #39's Level II PASRR. They confirmed that the level II
PASRR was not completed. They also stated that Resident #39 lived in a group home owned by his parents
prior to admission. When asked whether the resident had received a psychiatric evaluation, they stated, No.
They added that the facility did not have a psychiatric physician and residents were
(continued on next page)
Any deficiency statement ending with an asterisk (*) denotes a deficiency which the institution may be excused from correcting providing it is determined that other
safeguards provide sufficient protection to the patients. (See instructions.) Except for nursing homes, the findings stated above are disclosable 90 days following the
date of survey whether or not a plan of correction is provided. For nursing homes, the above findings and plans of correction are disclosable 14 days following the date
these documents are made available to the facility. If deficiencies are cited, an approved plan of correction is requisite to continued program participation.
LABORATORY DIRECTOR'S OR PROVIDER/SUPPLIER
REPRESENTATIVE'S SIGNATURE
TITLE
(X6) DATE
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Facility ID:
If continuation sheet
Page 1 of 4
Event ID:
105820
Printed: 05/28/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
105820
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
06/10/2021
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
University Crossing
6210 Beach Blvd
Jacksonville, FL 32216
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0645
Level of Harm - Minimal harm
or potential for actual harm
evaluated on an as-needed basis by the hospital psychiatric physician. The DON stated the facility did not
have a policy for PASRR.
.
Residents Affected - Few
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
105820
If continuation sheet
Page 2 of 4
Printed: 05/28/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
105820
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
06/10/2021
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
University Crossing
6210 Beach Blvd
Jacksonville, FL 32216
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0761
Level of Harm - Minimal harm
or potential for actual harm
Residents Affected - Few
Ensure drugs and biologicals used in the facility are labeled in accordance with currently accepted
professional principles; and all drugs and biologicals must be stored in locked compartments, separately
locked, compartments for controlled drugs.
**NOTE- TERMS IN BRACKETS HAVE BEEN EDITED TO PROTECT CONFIDENTIALITY** Based on
observations, interviews, and record reviews, the facility failed to ensure that drugs and biologicals used in
the facility were safely stored for two (Residents #321 and #322) in a total sample of 27 residents.
The findings include:
1. On 6/7/2021 at 10:30 AM, Resident #321 was observed lying in bed. There was a container of
medication observed on the bedside table. (Photographic evidence obtained) Resident #321 stated in an
interview on 6/7/21 at 10:35 AM that she was admitted to the facility on [DATE]. Upon arrival, she was
notified that her transplant medication was not available. She stated she had to ask a friend to bring the
medication from home, as she could not stay without it. She further stated she had been taking it as
prescribed.
A medical record review for Resident #321 indicated that she was admitted to the facility on [DATE] with a
diagnosis of kidney transplant. Physician's orders included mycophenolate mofetil (Cellcept) capsule 250
milligrams (mg), give 750 mg every 12 hours for transplant.
2. On 6/7/2021 at 11:00 AM, Resident #322 was observed seated in a reclining chair with the bedside table
in front of him. There was a bottle of nasal spray on the bedside table, and an anti-fungal powder was
observed on the resident's nightstand. (Photographic evidence obtained)
In an interview on 6/7/2021 at 11:30 AM, Resident #322 stated he used the nasal spray because at times,
he got a dry nose due to the use of oxygen. When asked about the powder on the nightstand, he stated he
had a groin infection and the nurses put the powder on daily.
On 6/9/2021 at 1:00 PM, the nasal spray and the anti-fungal powder medications were still at the bedside.
On 6/9/2021 at 2:08 PM, Employee B, Registered Nurse (RN), confirmed that the resident should not have
the antifungal powder or nasal spray at the bedside, as the resident had not been assessed for
self-administration of medication. She added that she would discuss it with the nurse responsible for the
resident's care.
A medical record review for Resident #322 indicated that the resident had skin irritation at the groin, and
Chronic Obstructive Pulmonary Disease (COPD). Current physician's orders revealed an order for
miconazole nitrate powder, apply to the groin for irritation, Oxygen 3 liters via nasal canula for COPD,
Ipratropium-Albuterol solution 0.5-2.5 (3) Mg/3 Milliliters (ML) vial, inhale orally every 8 hours (scheduled)
and every 8 hours as needed for COPD, Budesonide suspension 0.5mg/2ML inhale orally every 12 hours
for COPD. There were no orders for nasal spray.
In an interview on 6/9/2021 at 3:33 PM, Employee D, RN/Unit Manager, confirmed that the resident did not
have orders for nasal spray, nor should he have medications at the bedside. When asked about Resident
#321's and #322's assessments for self-administration, she stated neither resident had an assessment.
She added Resident #322 was very forgetful and therefore not a good candidate for self-administration.
She also mentioned that all medications were supposed to be in the medication/treatment
(continued on next page)
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
105820
If continuation sheet
Page 3 of 4
Printed: 05/28/2026
Form Approved OMB
No. 0938-0391
Department of Health & Human Services
Centers for Medicare & Medicaid Services
STATEMENT OF DEFICIENCIES
AND PLAN OF CORRECTION
(X1) PROVIDER/SUPPLIER/CLIA
IDENTIFICATION NUMBER:
(X2) MULTIPLE CONSTRUCTION
105820
B. Wing
A. Building
(X3) DATE SURVEY
COMPLETED
06/10/2021
NAME OF PROVIDER OR SUPPLIER
STREET ADDRESS, CITY, STATE, ZIP CODE
University Crossing
6210 Beach Blvd
Jacksonville, FL 32216
For information on the nursing home's plan to correct this deficiency, please contact the nursing home or the state survey agency.
(X4) ID PREFIX TAG
SUMMARY STATEMENT OF DEFICIENCIES
(Each deficiency must be preceded by full regulatory or LSC identifying information)
F 0761
carts at all times.
Level of Harm - Minimal harm
or potential for actual harm
Another interview was conducted with the Director of Nursing (DON) on 6/10/2021 at 9:00 AM. She stated
when a resident arrived at the facility, nurses were to make every effort to ensure that he/she received their
medications as ordered. She added there were times when some medications were not available due to
insurance coverage, and residents were asked to bring in their home prescription. In this case, the nurse
should have documentation indicating that the medication belonged to the resident, and medication should
be administered by the nurse and not left at the bedside. The DON also stated medications received from
the resident should be added to the inventory sheet. When asked about administration of over-the-counter
medications, she stated no medications should be administered without a physician's order.
Residents Affected - Few
A review of the facility's policy and procedure titled Nursing Medication Safety (Policy #UC NUR-014,
revised on 05/2021) revealed:
The purpose of this policy is to communicate safe medication practices to the nursing staff members,
patients and their families and facilitate medication safety at all times throughout their stay.
All RNs and LPNs will actively participate in safe medication practices in accordance with the procedures
specified.
1.Medications are to be administered to the Guest/Residents only when prescribed by a licensed physician.
4. Safe storage and handling of medication:
Upon delivery to nursing units, medications are kept in secure areas until administration. These areas
include medication rooms, medication carts and refrigerators.
5. Requirements for specific type of orders
i. Guest's own supply of medication of medication/self-administration: Policies and processes are not in
place as guest are not to self-administer medication and/or maintain medication at the bedside.
.
FORM CMS-2567 (02/99)
Previous Versions Obsolete
Event ID:
Facility ID:
105820
If continuation sheet
Page 4 of 4